4
Changes in Ownership
Bicara Therapeutics Inc. Filed Acc 0002034671-25-000006
Chief Executive Officer sold 24,103 shares at $18.83 ($453,761)
- Chief Executive Officer acquired 24,103 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mazumdar Claire Chief Executive Officer | 2025-10-16 | Option exercise 10b5-1 | +24,103 | $3.79 | $91,346 | 333,995 | D |
| Mazumdar Claire Chief Executive Officer | 2025-10-16 | Sale 10b5-1 | −24,103 | $18.83 | $453,761 | 309,892 | D |
| Derivatives | |||||||
| Mazumdar Claire Chief Executive Officer | 2025-10-16 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −24,103 | 277,270 | D | ||
| Open-market sales · 24,103 sh · avg $18.83 · $453,761 | |||||||
Loading xslF345X05/wk-form4_1760991057.xml…